Fiduciary Trust’s Pfizer PFE Stock Holding History

Fiduciary Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.05M	Sell	251,314 -43,065	-15%	-$1.13M	0.07%	153
2026 Q1	$8.27M	Sell	294,379 -3,787	-1%	-$101K	0.1%	123
2025 Q4	$7.42M	Sell	298,166 -1,202	-0.4%	-$30.3K	0.08%	132
2025 Q3	$7.63M	Sell	299,368 -353	-0.1%	-$8.71K	0.09%	133
2025 Q2	$7.27M	Sell	299,721 -19,564	-6%	-$456K	0.09%	134
2025 Q1	$8.09M	Buy	319,285 +41,300	+15%	+$1.08M	0.11%	118
2024 Q4	$7.37M	Sell	277,985 -28,265	-9%	-$767K	0.1%	126
2024 Q3	$8.86M	Sell	306,250 -17,661	-5%	-$515K	0.12%	115
2024 Q2	$9.06M	Sell	323,911 -13,160	-4%	-$362K	0.14%	106
2024 Q1	$9.35M	Sell	337,071 -33,446	-9%	-$928K	0.14%	105
2023 Q4	$10.7M	Sell	370,517 -55,639	-13%	-$1.68M	0.18%	95
2023 Q3	$14.1M	Sell	426,156 -21,549	-5%	-$762K	0.26%	69
2023 Q2	$16.4M	Sell	447,705 -21,541	-5%	-$838K	0.29%	63
2023 Q1	$19.1M	Sell	469,246 -12,127	-3%	-$524K	0.36%	56
2022 Q4	$24.7M	Sell	481,373 -1,916	-0.4%	-$91.9K	0.48%	44
2022 Q3	$21.1M	Sell	483,289 -1,335	-0.3%	-$64.9K	0.46%	45
2022 Q2	$25.4M	Sell	484,624 -12,568	-3%	-$640K	0.54%	40
2022 Q1	$25.7M	Sell	497,192 -27,277	-5%	-$1.42M	0.46%	44
2021 Q4	$31M	Sell	524,469 -25,074	-5%	-$1.24M	0.51%	38
2021 Q3	$23.6M	Buy	549,543 +875	+0.2%	+$38.8K	0.42%	46
2021 Q2	$21.5M	Sell	548,668 -26,053	-5%	-$1.01M	0.42%	49
2021 Q1	$20.8M	Sell	574,721 -13,190	-2%	-$468K	0.42%	52
2020 Q4	$21.6M	Buy	587,911 +8,506	+1%	+$312K	0.45%	49
2020 Q3	$20.2M	Buy	579,405 +6,815	+1%	+$239K	0.48%	46
2020 Q2	$17.8M	Buy	572,590 +2,157	+0.4%	+$73.3K	0.44%	50
2020 Q1	$17.7M	Sell	570,433 -16,283	-3%	-$555K	0.51%	45
2019 Q4	$21.8M	Sell	586,716 -8,678	-1%	-$309K	0.51%	47
2019 Q3	$20.3M	Buy	595,394 +34,199	+6%	+$1.24M	0.51%	46
2019 Q2	$23.1M	Buy	561,195 +625	+0.1%	+$24.8K	0.61%	42
2019 Q1	$22.6M	Sell	560,570 -6,709	-1%	-$269K	0.61%	43
2018 Q4	$23.5M	Sell	567,279 -12,127	-2%	-$503K	0.72%	34
2018 Q3	$24.2M	Buy	579,406 +1,026	+0.2%	+$39.5K	0.68%	37
2018 Q2	$19.9M	Sell	578,380 -7,248	-1%	-$248K	0.6%	44
2018 Q1	$19.7M	Buy	585,628 +3,495	+0.6%	+$120K	0.61%	47
2017 Q4	$20M	Sell	582,133 -1,551	-0.3%	-$52.9K	0.59%	52
2017 Q3	$19.8M	Sell	583,684 -6,728	-1%	-$216K	0.61%	51
2017 Q2	$18.8M	Sell	590,412 -13,801	-2%	-$435K	0.58%	51
2017 Q1	$19.6M	Buy	604,213 +6,243	+1%	+$197K	0.6%	47
2016 Q4	$18.4M	Sell	597,970 -12,131	-2%	-$370K	0.6%	51
2016 Q3	$19.6M	Buy	610,101 +11,616	+2%	+$388K	0.67%	44
2016 Q2	$20M	Sell	598,485 -10,693	-2%	-$341K	0.7%	40
2016 Q1	$17.1M	Buy	609,178 +51,923	+9%	+$1.48M	0.61%	51
2015 Q4	$17.1M	Buy	557,255 +99,129	+22%	+$3.12M	0.72%	46
2015 Q3	$13.7M	Buy	458,126 +110,626	+32%	+$3.55M	0.62%	49
2015 Q2	$11.1M	Buy	347,500 +55,273	+19%	+$1.8M	0.46%	63
2015 Q1	$9.65M	Sell	292,227 -26,184	-8%	-$832K	0.4%	72
2014 Q4	$9.41M	Buy	318,411 +4,362	+1%	+$125K	0.4%	72
2014 Q3	$8.81M	Sell	314,049 -1,099	-0.3%	-$30.8K	0.39%	70
2014 Q2	$8.88M	Sell	315,148 -8,063	-2%	-$230K	0.38%	71
2014 Q1	$9.85M	Buy	323,211 +2,846	+0.9%	+$84.9K	0.44%	67
2013 Q4	$9.31M	Buy	320,365 +2,813	+0.9%	+$81.9K	0.41%	69
2013 Q3	$8.65M	Sell	317,552 -3,151	-1%	-$85.7K	0.4%	71
2013 Q2	$8.52M	Buy	+320,703	New	+$8.86M	0.39%	70

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fiduciary Trust's PFE Position: Q2 2026 in Review

Fiduciary Trust reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $1.13M and leaving 251,314 shares worth $6.05M. The position accounts for 0.07% of the portfolio, ranked #153.

Fiduciary Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $31M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Fiduciary Trust held 251,314 shares of Pfizer worth $6.05M as of Q2 2026.
Fiduciary Trust sold 43,065 Pfizer shares in Q2 2026, an estimated $1.13M.
Pfizer made up 0.07% of Fiduciary Trust's portfolio in Q2 2026, its #153 holding.
Fiduciary Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Fiduciary Trust's Pfizer position peaked at $31M in Q4 2021.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.